Clinical features of nosocomial infections by extended-spectrum β-lactamase-producing Enterobacteriaceae in neonatal intensive care units

被引:13
作者
Chiu, S
Huang, YC
Lien, RI
Chou, YH
Lin, TY
机构
[1] Chang Gung Childrens Hosp, Div Pediat Infect Dis, Taoyuan 333, Taiwan
[2] Chang Gung Childrens Hosp, Div Neonatol, Taoyuan 333, Taiwan
[3] Chang Gung Univ, Taoyuan, Taiwan
关键词
extended-spectrum beta-lactamase; neonatal intensive care unit; Klebsiella pneumoniae; Escherichia coli; carbapenem;
D O I
10.1080/08035250510037704
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aim: To determine the risk factors for the acquisition of nosocomial extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae infection in infants hospitalized in neonatal intensive care units (NICUs) and to evaluate the therapeutic outcome of these infants. Methods: We retrospectively reviewed the medical records of infants with nosocomial ESBL-producing Enterobacteriaceae infection hospitalized in NICUs at Chang Gung Children's Hospital in 2001. The clinical features of these infants were compared with a cohort of non-ESBL-producing Enterobacteriaceae-infected infants during the same period. The therapeutic outcome of the infants in the ESBL group was analysed. Results: Seventy infants were included in this study. Thirty-one infants with 34 isolates were identified in the ESBL group and 39 infants with 42 isolates in the non-ESBL group. Of the parameters analysed, including gestational age, birthweight, length of hospital stay before onset, the number of antibiotics used, the duration of third-generation cephalosporin usage and the number of patients receiving a third-generation cephalosporin prior to the onset of infection, no significant difference was found between the two groups. The infection-contributed case fatality rate was 3.0% (1 of 33) in the ESBL group, not significantly different from that in the non-ESBL group (1 of 41, 2.4%). Of the 31 patients in the ESBL group, 18 were treated with a carbapenem as definitive therapy while 13 were treated with a non-carbapenem antibiotic regimen. No significant difference was noted in terms of mortality rate between the two subgroups. Conclusion: The outcome of the infants hospitalized in the NICU with ESBL-producing enterobacterial infections was not indispensably grave, even when treated with a non-carbapenem antibiotic regimen. The risk factors for the acquisition of ESBL-producing enterobacterial infections in these infants were not identified in this series.
引用
收藏
页码:1644 / 1649
页数:6
相关论文
共 28 条
[11]   Bloodstream infections by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children:: Epidemiology and clinical outcome [J].
Kim, YK ;
Pai, H ;
Lee, HJ ;
Park, SE ;
Choi, EH ;
Kim, J ;
Kim, JH ;
Kim, EC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1481-1491
[12]   TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS [J].
KNOTHE, H ;
SHAH, P ;
KRCMERY, V ;
ANTAL, M ;
MITSUHASHI, S .
INFECTION, 1983, 11 (06) :315-317
[13]   Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes [J].
Lautenbach, E ;
Patel, JB ;
Bilker, WB ;
Edelstein, PH ;
Fishman, NO .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (08) :1162-1171
[14]   Extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in the high-prevalence area of Athens, Greece [J].
Lebessi, E ;
Dellagrammaticas, H ;
Tassios, PT ;
Tzouvelekis, LS ;
Ioannidou, S ;
Foustoukou, M ;
Legakis, NJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :799-804
[15]   Extended-spectrum beta-lactamases and other enzymes providing resistance to oxyimino-beta-lactams [J].
Leggiadro, RJ .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1997, 11 (04) :875-&
[16]   A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure [J].
Macrae, MB ;
Shannon, KP ;
Rayner, DM ;
Kaiser, AM ;
Hoffman, PN ;
French, GL .
JOURNAL OF HOSPITAL INFECTION, 2001, 49 (03) :183-192
[17]   NOSOCOMIAL OUTBREAK OF KLEBSIELLA INFECTION RESISTANT TO LATE-GENERATION CEPHALOSPORINS [J].
MEYER, KS ;
URBAN, C ;
EAGAN, JA ;
BERGER, BJ ;
RAHAL, JJ .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (05) :353-358
[18]  
National Committee for Clinical Laboratory Standards, 2001, M2A7 NCCLS
[19]   Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) [J].
Paterson, DL .
CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (09) :460-463
[20]   Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases:: Implications for the clinical microbiology laboratory [J].
Paterson, DL ;
Ko, WC ;
Von Gottberg, A ;
Casellas, JM ;
Mulazimoglu, L ;
Klugman, KP ;
Bonomo, RA ;
Rice, LB ;
McCormack, JG ;
Yu, VL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (06) :2206-2212